Journal List > Ann Dermatol > v.21(3) > 1045125

Lee, Kim, Kim, and Park: A Case of Post-zoster Eosinophilic Dermatosis

Abstract

Post-zoster eosinophilic dermatosis is a rare disease that occurs as an isotopic response in the region of previously healed herpes zoster. We report here on a case of post-zoster eosinophilic dermatosis that occurred 13 years after an episode of herpes zoster. A 48-year-old woman presented with several pruritic, brown papules and plaques in the same dermatome where her previous episode of herpes zoster had healed. Histopathologically, there was a dermal inflammatory cell infiltration composed of abundant eosinophils, lymphocytes and histiocytes. Based on these clinicopathologic findings, the patient was diagnosed with post-zoster eosinophilic dermatosis.

INTRODUCTION

Post-zoster eosinophilic dermatosis is one of the isotopic responses that occur in the region of healed herpes zoster. It was first described by Mitsuhashi and Kondo1 in 1997. The lesions in the first reported case clinically appeared as sharply demarcated brown plaques. Histologically, the lesions were characterized by a dermal infiltration of eosinophils and lymphocytes without atypicality. The dermatosis resolved one month after the application of topical steroid for 2 weeks1. To the best of our knowledge, only one case of post-zoster eosinophilic dermatosis, as an isotopic response, has been reported in the English medical literatures1. We report here on another case of post-zoster eosinophilic dermatosis in a 48-year-old woman with a history of herpes zoster infection.

CASE REPORT

A 48-year-old female patient presented to our department with several severely pruritic, sharply demarcated, erythematous to brown papules and plaques with fine scales on her right flank (Fig. 1). The lesions had slowly developed for the past 6 months. The patient had no history of an insect bite, trauma or medication. Her medical history included herpes zoster along the T10 dermatome of the right flank, and this had had been successfully treated with an oral antiviral agent (Acyclovir, Vacrax®, 4,000 mg/day, 7 days) 13 years previously and she had residual scars. On laboratory examination, the complete blood cell count was within the normal limits. Eosinophils accounted for 3.8% (0~5%) of the peripheral white blood cells, and the total serum IgE level was 91.2 ku/L (<100 ku/L). The erythrocyte sedimentation rate was increased (35 mm/h). The skin biopsy specimen obtained from a plaque on the right flank revealed mild acanthosis and spongiosis in the epidermis and a perivascular inflammatory cell infiltration composed of abundant eosinophils, lymphocytes and histiocytes in the dermis (Fig. 2). There was no granulomatous change. An application of a topical steroid (Dethasone ointment®, bid) for 2 weeks resulted in the lesions clearing up; no sign of recurrence was noted 6 months after treatment.

DISCUSSION

Wolf et al.2 define an isotopic response as the occurrence of a new skin disorder at the site of another unrelated and already healed skin disease. The first disease in most of these cases is herpes zoster, and several cutaneous reactions have been described in the dermatomes affected by herpes zoster3. The second diseases may be granulomatous reactions (mainly granuloma annulare), malignancies (single tumor and leukemic or lymphomatous infiltration), immune disorders (e.g. lichen planus, allergic contact dermatitis), infections (viral, bacterial, fungal) and others (e.g. acneiform lesions, reactive perforating collagenosis)3-5. Seven cases of postherpetic isotopic reactions have currently been reported in the Korean dermatologic literature (Table 1)6-13.
The pathogenesis of isotopic responses is unclear. Several possibilities have been considered: a viral origin, an immunologic origin, a vascular origin and a neural origin. Concerning a viral origin, it has been suggested that either the virus is directly responsible for the second disease, or the second disease is the result of an inflammatory reaction that develops in response to residual viral antigens or to the tissue damage. Polymerase chain reaction has been used to investigate the skin lesions for the presence of varicella-zoster virus, which has been consistently found only in the early lesions3. The development of post-zoster dermatosis may be influenced by long-lasting immunologic changes, alterations in the microcirculation or the destruction of A δ and C nerve fibers that occurs after viral infection of the skin4,14.
Our patient presented with several erythematous to brown papules and plaques with fine scales on the T10 dermatome in the area of a previous zoster infection. The clinical differential diagnosis in this case included granuloma annulare and lichen planus. However, the absence of any histological granulomatous change ruled out the possibility of granuloma annulare. Lichen planus was also excluded because of the absence of the characteristic histological findings such as basal layer vacuolization, Civatte bodies and a band-like inflammatory cell infiltration. Instead, one of the most pronounced histological features in our case was a prominent eosinophil infiltration in the lesion. Thus, we needed to further exclude the possibility of drug eruption and insect bites, but the patient denied any medication history or insect bite history, and peripheral eosinophilia was not detected. Based on these clinical and histopathological findings, we diagnosed our case as post-zoster eosinophilic dermatosis. Post-zoster eosinophilic dermatosis is one of the isotopic responses, and these are clinically and histopathologically distinct from the other known dermatoses. It occurs on the region of the healed herpes zoster and it is histologically characterized by a dermal infiltration of eosinophils.
In an isotopic response, the time elapsing between the first disease and the second one widely varies, ranging from days to years1-4. In our patient, the delay was approximately 13 years. Until we better understand the pathogenesis of the isotopic response, it will be difficult to design targeted therapies3,7. Langenberg et al.15 suggest that antiviral therapy may not be appropriate in inflammatory post-zoster conditions. Instead, topical or systemic corticosteroids are often used7,15,16. Most post-zoster conditions are self-limited in nature, but these lesions should be examined histologically because of the possibility of occurrence of some malignancies such as lymphoma and Kaposi's sarcoma16,17.

Figures and Tables

Fig. 1
Several erythematous to brown papules and plaques with fine scales along the T10 dermatome on the right flank. Inset: a magnified view.
ad-21-274-g001
Fig. 2
(A) A biopsy specimen obtained from a representative plaque showed mild acanthosis and spongiosis in the epidermis and a perivascular inflammatory cell infiltration in the dermis (H&E, ×25). (B) The dermal perivascular inflammatory cell infiltration was composed of lymphocytes and histiocytes, along with abundant eosinophils (H&E, ×400).
ad-21-274-g002
Table 1
Summary of the postherpetic isotopic responses that were previously reported in the Korean dermatologic literatures
ad-21-274-i001

*Time interval between the resolution of herpes zoster and the appearance of the second cutaneous lesions

Notes

This article was presented at the 60th Annual Spring Meeting of the Korean Dermatological Association on April 16~17, 2008.

References

1. Mitsuhashi Y, Kondo S. Post-zoster eosinophilic dermatosis. Br J Dermatol. 1997. 136:465–466.
crossref
2. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995. 34:341–348.
crossref
3. Gibney MD, Nahass GT, Leonardi CL. Cutaneous reactions following herpes zoster infections: report of three cases and a review of the literature. Br J Dermatol. 1996. 134:504–509.
crossref
4. Ruocco V, Ruocco E, Ghersetich I, Bianchi B, Lotti T. Isotopic response after herpesvirus infection: an update. J Am Acad Dermatol. 2002. 46:90–94.
crossref
5. Requena L, Kutzner H, Escalonilla P, Ortiz S, Schaller J, Rohwedder A. Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol. 1998. 138:161–168.
crossref
6. Park SJ, Lee SH, Lee HG, Kim JM. A case of acneiform eruption on the healed site of herpes zoster. Korean J Dermatol. 1997. 35:994–996.
7. Park HJ, Lee JH, Kim YC, Cinn YW. Post-zoster granuloma. Ann Dermatol. 1998. 10:64–66.
crossref
8. Park JG, Lee DW, Lee JY, Kang SJ, Cho BK. Reactive perforating collagenosis arising at the site ofhealed herpes zoster. Korean J Dermatol. 2000. 38:136–138.
9. Kim YJ, Hwang ES, Kim IH, Yu DS. A case of benign fibrous histiocytoma on herpes zoster scar: Wolf's isotopic response. Ann Dermatol. 2004. 16:134–137.
crossref
10. Suh KS, Choi SY, Jeon YS, Sim HJ, Kim ST. A case of granuloma annulare occurring on herpes zoster. Korean J Dermatol. 2005. 43:834–836.
11. Kim JS, Kim MH, Choi HY, Myung KB. A case of zosteriform lichen planus occurring on herpes zoster lesions. Korean J Dermatol. 2004. 42:217–219.
12. Choi HJ, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. A case of zosteriform lichen planus on the site of healed herpes zoster: Wolf's isotopic response. Korean J Dermatol. 2004. 42:456–459.
13. Na SY, Lee HY, Baek JO, Roh JY, Lee JR. A case of cutaneous zosteriform metastatic carcinoma arising on the healed site of herpes zoster. Korean J Dermatol. 2008. 46:347–351.
14. Ebert MH. Histologic changes in sensory nerves of the skin in herpes zoster. Arch Derm Syphilol. 1949. 60:641–648.
crossref
15. Langenberg A, Yen TS, LeBoit PE. Granulomatous vasculitis occurring after cutaneous herpes zoster despite absence of viral genome. J Am Acad Dermatol. 1991. 24:429–433.
crossref
16. Niedt GW, Prioleau PG. Kaposi's sarcoma occurring in a dermatome previously involved by herpes zoster. J Am Acad Dermatol. 1988. 18:448–451.
crossref
17. Aloi FG, Appino A, Puiatti P. Lymphoplasmocytoid lymphoma arising in herpes zoster scars. J Am Acad Dermatol. 1990. 22:130–131.
crossref
TOOLS
ORCID iDs

Young Min Park
https://orcid.org/http://orcid.org/0000-0002-3631-0807

Similar articles